Tag Archives: Ranbaxy

GSK cops $3 bn fine for largest health care fraud in US; 17th Edition of Medicines Australia Code released

Not surprisingly, these two news items led to a discussion on Australian television (and elsewhere) of whether the promotional activities of the pharmaceutical industry should be governed by self-regulatory industry codes of conduct or by co-regulation involving the government and … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , | Leave a comment